Navigation Links
Allied Healthcare's Net Suffers on Flat Sales, Performance Issues

ST. LOUIS, Feb. 8 /PRNewswire-FirstCall/ -- Allied Healthcare Products, Inc. (Nasdaq: AHPI) reported today that its net income in the second quarter ending December 31 fell almost 98 percent from $293,000 last year, or 4 cents per share, to about $6,500 in the current quarter, or zero cents per share.

For the first half of the 2008 fiscal year ending December 31, net income fell about 81 percent, from about $495,000 last year, or six cents per share, to about $93,500, or one cent per share, in the current fiscal year.

Customer orders for the first two quarters of fiscal 2008 were consistent with those of the prior year, declining only about $235,000. Sales, however, which depend on customer purchase order releases, declined about $1,000,000 or 3.6 percent, for the first two quarters of this fiscal year. Customer release rates are expected to return to more normal levels in the second half of the year, Allied said.

The sharp decline in net income resulted from gross margins that fell by about $960,000 compared to last year. Low production levels, caused by lower sales, combined with decreases in inventory to result in lower absorption of fixed costs. Also, cost reduction programs to offset higher labor and material costs did not take effect as planned in the first two quarters.

Material costs increased by 2.2 percent and labor costs by 4.5 percent compared to the previous year, Allied said. "Those increases should have been offset by cost reduction efforts, but we failed to execute in the first two quarters," said Earl Refsland, Allied president and chief executive officer. Difficulties in introducing a new product contributed to production delays, Refsland said.

"We know what we have to do to correct problems we encountered," Refsland said. "We just have to focus on the basics and execute."

Despite difficulties, Allied once again improved its cash position, Refsland said. The company had a cash balance of about $4.7 million at the end of the first half of the fiscal year, an increase of more than 17 percent over the previous quarter and 30 percent over the previous year end.

Allied Healthcare Products, Inc. is a leading manufacturer of respiratory care products, medical gas equipment and emergency medical products used in a wide range of alternate care settings.

"SAFE HARBOR" STATEMENT: Statements contained in this release that are not historical facts or information are "forward-looking statements." Words such as "believe," "expect," "intend," "will," "should," and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward-looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company's operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made.




Three months ended, Six months ended,

December 31, December 31,

2007 2006 2007 2006

Net sales $13,626,016 $14,273,950 $27,727,634 $28,751,392

Cost of sales 10,714,172 10,757,222 21,648,777 21,715,111

Gross profit 2,911,844 3,516,728 6,078,857 7,036,281

Selling General and


expenses 2,932,428 3,091,418 5,975,398 6,282,415

Income (loss) from

operations (20,584) 425,310 103,459 753,866

Interest income (38,177) (28,059) (78,946) (56,228)

Other, net 11,113 (53,182) 26,263 (43,878)

(27,064) (81,241) (52,683) (100,106)

Income before provision

for income taxes 6,480 506,551 156,142 853,972

Provision for income

taxes - 213,395 62,597 359,183

Net income $6,480 $293,156 $93,545 $494,789

Net income per share

- Basic and diluted $0.00 $0.04 $0.01 $0.06

Weighted average common


Outstanding -

Basic 7,883,577 7,877,120 7,883,577 7,868,512

Weighted average common


Outstanding -

Diluted 8,130,901 8,059,573 8,122,607 8,064,650




December 31, 2007 June 30, 2007


Current assets:

Cash and cash equivalents $4,732,692 $3,638,870

Accounts receivable, net of

allowances of $325,000 and

$460,000, respectively 6,190,756 7,251,767

Inventories, net 11,810,149 12,999,472

Other current assets 523,486 275,254

Total current assets 23,257,083 24,165,363

Property, plant and equipment, net 10,267,716 10,677,000

Goodwill 15,979,830 15,979,830

Other assets, net 562,161 496,127

Total assets $50,066,790 $51,318,320


Current liabilities:

Accounts payable $2,719,389 $3,040,313

Other accrued liabilities 1,945,603 2,508,820

Deferred income taxes 726,861 882,001

Deferred revenue 465,000 465,000

Total current liabilities 5,856,853 6,896,134

Deferred revenue 1,705,000 1,937,500

Commitments and contingencies

Stockholders' equity:

Preferred stock; $0.01 par value;

1,500,000 shares authorized; no

shares issued and outstanding - -

Series A preferred stock; $0.01 par

value; 200,000 shares authorized; no

shares issued and outstanding - -

Common stock; $0.01 par value; 30,000,000

shares authorized; 10,187,069 shares

issued at December 31, 2007 and June 30,

2007; 7,883,577 shares outstanding at

December 31, 2007 and June 30, 2007 101,871 101,871

Additional paid-in capital 47,479,012 47,441,163

Retained earnings 15,655,482 15,673,080

Less treasury stock, at cost;

2,303,492 shares at December 31, 2007

and June 30, 2007, respectively (20,731,428) (20,731,428)

Total stockholders' equity 42,504,937 42,484,686

Total liabilities and

stockholders' equity $50,066,790 $51,318,320

SOURCE Allied Healthcare Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
2. SIEMENS, AlliedBarton, Methodist Hospital, and Family Planning Council Win Human Resources Department of the Year Awards
3. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
4. AWWA Water 101 Seminar Targets Sales, Marketing and PR Pros
5. Mastering Challenges & Measuring Successes for Quality Initiatives in Sales, Marketing and Product Development
6. Tailor Quality Initiatives to Improve Sales, Marketing & New Product Development
7. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
8. End-to-End HR Performance Benchmarks: Metrics That Will Help Turn the HR Cost Center into a Productivity Driver
9. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
10. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
11. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma ... as the company,s second affiliate in Latin America . ... ... Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016 ... "Surgical Procedure Volumes: Global Analysis (United States, China, ... Canada)" report to their offering. ... essential tool for healthcare business planners, provides surgical procedure ... at surgery trends with an in-depth analysis of growth ...
Breaking Medicine Technology: